Park Place Capital’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-87
Closed -$1.9K 816
2025
Q2
$1.9K Hold
87
﹤0.01% 734
2025
Q1
$2.14K Buy
+87
New +$2.15K ﹤0.01% 725
2024
Q4
Sell
-118
Closed -$3.2K 849
2024
Q3
$3.2K Hold
118
﹤0.01% 731
2024
Q2
$3.39K Sell
118
-108
-48% -$3.31K ﹤0.01% 733
2024
Q1
$6.59K Hold
226
﹤0.01% 707
2023
Q4
$7.35K Sell
226
-436
-66% -$12.6K ﹤0.01% 671
2023
Q3
$21.2K Hold
662
0.01% 631
2023
Q2
$29K Hold
662
0.01% 584
2023
Q1
$29.3K Hold
662
0.01% 577
2022
Q4
$26K Buy
+662
New +$27.6K 0.01% 602

Other funds holding KIDS

Park Place Capital's KIDS Position: Q3 2025 in Review

Park Place Capital sold out of OrthoPediatrics (KIDS) in Q3 2025, closing a stake of 87 shares — an estimated $1.9K sold.

Park Place Capital first reported a position in KIDS in Q4 2022 and held it in 10 quarters. The position peaked at $29.3K in Q1 2023. 111 funds tracked by Wall St. Rank hold KIDS as of Q3 2025.

  • Park Place Capital reported no remaining OrthoPediatrics position as of Q3 2025 after selling out during the quarter.
  • Park Place Capital sold 87 OrthoPediatrics shares in Q3 2025, an estimated $1.9K.
  • Park Place Capital first reported a position in OrthoPediatrics in Q4 2022 and held it in 10 quarters.
  • Park Place Capital's OrthoPediatrics position peaked at $29.3K in Q1 2023.
  • 111 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2025.

Based on Park Place Capital's 13F filing for Q3 2025, filed 22 Oct 2025.